SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-025857
Filing Date
2020-09-09
Accepted
2020-09-09 16:13:37
Documents
2
Period of Report
2020-09-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea126629-8k_oramedpharma.htm 8-K 30898
2 CLINICAL RESEARCH ORGANIZATION SERVICES AGREEMENT DATED SEPTEMBER 2, 2020 AND EF ea126629ex10-1_oramed.htm EX-10.1 735502
  Complete submission text file 0001213900-20-025857.txt   767739
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 001-35813 | Film No.: 201166668
SIC: 2834 Pharmaceutical Preparations